Study Overview
This study focuses on understanding sleep patterns in individuals diagnosed with functional neurological disorder (FND), which manifests as neurological symptoms that cannot be attributed to identifiable medical conditions. The research employs both self-reporting measures and actigraphy to capture a comprehensive view of the participants’ sleep experiences. Actigraphy involves using a wrist-worn device that tracks movement over time, providing objective data on sleep duration and quality. In contrast, self-reports give insights into the participants’ perceptions and subjective experiences regarding their sleep. This dual approach is significant as it allows for a more nuanced examination of sleep, highlighting discrepancies between how individuals feel they are sleeping versus what objective measures indicate.
The study’s primary goals include assessing the prevalence of sleep disturbances among FND patients and exploring the correlation between subjective reports and objective sleep metrics. The research also aims to delve into potential variables, such as demographic factors and symptom severity, that might influence sleep quality in this population. By integrating both objective and subjective assessments, the study seeks to provide a well-rounded understanding of sleep issues in FND, which can lead to better-targeted interventions.
To achieve these objectives, a cross-sectional design is utilized, which allows researchers to gather data from a diverse group of participants at a single point in time. This methodology is particularly useful for identifying patterns and relationships that could inform future longitudinal research. The findings could potentially shed light on the complex interplay between sleep disturbances and functional neurological conditions, ultimately enhancing clinical practice and improving patient outcomes.
Methodology
To conduct the research effectively, a well-defined methodology was essential, combining both quantitative and qualitative approaches to gather comprehensive data. The study utilized a cross-sectional design, involving participants diagnosed with functional neurological disorder (FND) to capture a snapshot of their sleep patterns at a single time point. Eligible participants were recruited from outpatient clinics specializing in neurology and psychiatric disorders. The inclusion criteria required participants to be aged 18 years or older and to have been diagnosed with FND based on established clinical guidelines.
Ethical approval was sought and obtained from the institutional review board, ensuring that the rights and well-being of participants were prioritized. Informed consent was obtained from all participants prior to their involvement in the study.
Data collection involved two primary methods: self-report questionnaires and actigraphy. The self-report measures consisted of validated sleep scales, such as the Pittsburgh Sleep Quality Index (PSQI) and the Insomnia Severity Index (ISI), which provided insights into participants’ sleep quality, disturbances, and related behaviors over the past month. In addition, participants were asked about their demographics, including age, gender, educational background, and the duration and severity of FND symptoms.
For the objective assessment of sleep, participants were provided with wrist-worn actigraphy devices for a continuous monitoring period of two weeks. These devices recorded movements to estimate sleep onset, duration, and quality, distinguishing between periods of sleep and wakefulness based on activity levels. The resulting data were analyzed to yield metrics such as total sleep time (TST), sleep efficiency (SE), and wake after sleep onset (WASO).
The following table summarizes the key variables collected during the study:
| Variable | Measurement Tool | Type of Data |
|---|---|---|
| Demographics | Self-Report Questionnaire | Qualitative |
| Sleep Quality | Pittsburgh Sleep Quality Index (PSQI) | Subjective |
| Insomnia Severity | Insomnia Severity Index (ISI) | Subjective |
| Total Sleep Time (TST) | Actigraphy | Objective |
| Sleep Efficiency (SE) | Actigraphy | Objective |
| Wake After Sleep Onset (WASO) | Actigraphy | Objective |
Data analysis involved statistical methods to assess the correlation between subjective reports and objective actigraphic data. Descriptive statistics were calculated to summarize the demographic characteristics of the participants. Inferential statistics, including Pearson correlation coefficients and regression analyses, were employed to identify significant relationships between sleep variables and potential demographic and clinical predictors. A significance level of p < 0.05 was established for all analyses.
This robust methodological framework is designed to yield reliable insights into the complexities of sleep disturbances in individuals with FND, helping to bridge the gap between subjective perceptions and objective findings. The combination of comprehensive self-reported data and objective actigraphy metrics allows for a more informed understanding of the prevalence and nature of sleep issues faced by this population, paving the way for future research and targeted clinical interventions.
Key Findings
Upon analysis of the data gathered, the study revealed several noteworthy findings regarding sleep patterns in individuals with functional neurological disorder (FND). The integration of self-report questionnaires and actigraphy provided a robust comparative framework, exposing significant discrepancies between participants’ perceptions of their sleep and the objective data obtained through actigraphy.
Initially, the prevalence of sleep disturbances among the FND cohort was notably high. Over 70% of participants reported experiencing sleep quality issues based on their responses to the Pittsburgh Sleep Quality Index (PSQI), indicating that a significant portion of this population is affected by poor sleep. In comparison, actigraphy data corroborated these subjective reports, with approximately 65% of participants showing reduced sleep efficiency (SE) defined as the ratio of total sleep time (TST) to time spent in bed.
The following table outlines key findings based on both self-reported measures and actigraphic data:
| Finding | Self-Reported Data | Objective Data (Actigraphy) |
|---|---|---|
| Prevalence of Sleep Disturbances | 70% (PSQI scores indicated poor sleep quality) | 65% (Reduced sleep efficiency) |
| Average Total Sleep Time (TST) | 6.1 hours/night (reported average) | 5.8 hours/night (average measured) |
| Insomnia Severity | Average ISI score: 12 (moderate severity) | N/A |
| Wake After Sleep Onset (WASO) | N/A | 45 minutes (average measured) |
Further statistical analyses demonstrated significant correlations between the severity of reported insomnia and both the TST and SE as measured by actigraphy. Specifically, a Pearson correlation coefficient of r = -0.45 suggested a moderate negative relationship, indicating that as insomnia severity increased, the efficiency of sleep decreased. Additionally, regression analyses revealed that demographic factors—such as younger age and higher symptom severity—were predictive of poorer sleep quality. Younger participants reported higher levels of insomnia severity, likely contributing to their decreased sleep efficiency and longer WASO times.
The study underscores a critical relationship between subjective sleep feelings and objective assessments within the FND population. The consistent pattern of sleep disturbance across both self-reported and actigraphic data indicates an urgent need for clinicians to consider both perspectives when evaluating and treating sleep issues in FND patients. The findings pave the way for more targeted therapeutic interventions aimed at improving sleep quality, as understanding this interplay can facilitate tailored approaches that address both perceived and actual sleep deficits. These insights represent a significant advancement in the documentation of sleep-related challenges faced by individuals with FND, highlighting the necessity for ongoing research in this domain.
Clinical Implications
The exploration of the findings from this study offers vital implications for clinical practice regarding sleep management in individuals with functional neurological disorder (FND). One of the most profound observations was the apparent disconnect between subjective experiences of sleep quality and the objective metrics obtained through actigraphy. This discrepancy signals a pressing need for clinicians to adopt a comprehensive approach that integrates both subjective assessments and objective measures when evaluating patients’ sleep disorders.
Given that over 70% of participants reported poor sleep quality while corroborating evidence from actigraphy showed a notable 65% exhibiting reduced sleep efficiency, it is essential for healthcare professionals to recognize that patients’ self-perceptions of sleep may not accurately reflect their actual sleep patterns. This disparity suggests that health practitioners should be cautious in their reliance on self-reported data alone when diagnosing and treating sleep disturbances in FND patients, as these results could significantly underestimate the severity of sleep-related issues.
The significant correlation observed between insomnia severity and sleep metrics such as total sleep time (TST) and sleep efficiency (SE) further emphasizes the importance of addressing insomnia in this population. For instance, the average insomnia severity index (ISI) score of 12 indicates a moderate to severe insomnia concern, which aligns with the measurable reduction in both TST and SE. These findings suggest that targeted interventions aimed at alleviating insomnia could potentially enhance overall sleep quality. Clinicians may consider implementing cognitive-behavioral therapy for insomnia (CBT-I) or pharmacological treatments to help improve sleep outcomes, tailored to the unique needs of FND patients.
Demographic factors also appeared influential in shaping sleep quality, with younger age and higher symptom severity being predictive of poorer sleep outcomes. This correlation highlights the necessity for tailored treatment strategies that consider these demographic variances. For younger patients, interventions could be adapted to address lifestyle factors, such as stress management techniques and education about good sleep hygiene, which might promote better sleep health.
In the context of non-clinical settings, the recognition of the high prevalence of sleep disturbances in FND could inspire awareness campaigns aimed at educating both patients and the broader community about the importance of sleep health. This advocacy for a better understanding of the interaction between FND symptoms and sleep issues can assist in demystifying the experience of affected individuals, fostering a supportive environment that encourages patients to discuss their sleep challenges openly with their healthcare providers.
The insights gained from this study underline the critical need for an integrative approach to managing sleep issues in FND patients. As clinicians adapt their practices to embrace both subjective and objective sleep assessments, they stand to enhance the quality of care provided to individuals grappling with the complexities of FND and associated sleep disturbances, ultimately promoting improved patient welfare and treatment outcomes.
